汇宇制药股价跌5.24%，大成基金旗下1只基金重仓，持有43.15万股浮亏损失47.46万元

Group 1 - The core point of the news is that Sichuan Huiyu Pharmaceutical Co., Ltd. experienced a stock decline of 5.24%, with a current share price of 19.90 yuan and a total market capitalization of 8.43 billion yuan [1] - The company was established on October 12, 2010, and went public on October 26, 2021, focusing on the research, production, and sales of oncology drugs and complex injectable drugs [1] - The main revenue composition of the company includes 97.27% from drug sales, 1.66% from technical services, and 1.07% from other sources [1] Group 2 - From the perspective of fund holdings, Dachen Fund has a significant position in Huiyu Pharmaceutical, with its Dachen Medical Health Stock A fund holding 431,500 shares, accounting for 4.07% of the fund's net value [2] - The Dachen Medical Health Stock A fund has a current scale of 153 million yuan and has achieved a year-to-date return of 28.54%, ranking 1895 out of 4220 in its category [2] - The fund manager, Yang Ting, has been in the position for 11 years and 114 days, with the best fund return during his tenure being 77.63% [2]